Clinical studies status (June 2023)

2023-09-01T20:16:11+00:00September 1st, 2023|Clinical Studies|

During year 4, huge progress has been done in the enrolment of patients in the clinical studies within the TransBioLine project to move forward in the identification of novel biomarkers that reliably indicate specific organ [...]

WP4 LOI accepted by the FDA!

2022-03-23T15:40:21+00:00April 8th, 2020|Clinical Studies|

The TransBioLine WP4 (Biomarkers of vascular injury) Letter of Intent was accepted by the FDA on February 2020 and the team is in preparation to discuss the FDA recommendations to [...]

Go to Top